SCHEMBL30166986

SCHEMBL30166986

CN(C)c1cccc(Oc2ccc3[nH]c(=O)[nH]c3c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 1/20 0.47
▸ CHEK2 O96017 1/20 0.45
▸ GRIA1 P42261 2/20 0.41
▸ CACNG8 Q8WXS5 2/20 0.41
▸ DRD2 P14416 1/20 0.40
▸ NOTUM Q6P988 1/20 0.40
▸ PDE3B Q13370 1/20 0.40
▸ PDE3A Q14432 1/20 0.40
▸ MAPT P10636 2/20 0.39
▸ ALPL P05186 1/20 0.39
▸ ALPI P09923 1/20 0.39
▸ ALPG P10696 1/20 0.39
▸ FFAR1 O14842 1/20 0.39
▸ APP P05067 1/20 0.39
▸ BCHE P06276 2/20 0.39
▸ ACHE P22303 1/20 0.39
▸ ESR2 Q92731 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ HSD17B1 P14061 1/20 0.38
▸ HSD17B2 P37059 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28967624 1.00 BRAF (0.47) BRAFCHEK2GRIA1CACNG8DRD2
SCHEMBL28967629 0.79 PDE3B (0.53) DRD2PDE3BPDE3AMAPTESR2
SCHEMBL30085363 0.79 ALDH1A1 (0.52) CHEK2MAPTFFAR1APPBCHE
SCHEMBL390876 0.79 ALDH1A1 (0.52) CHEK2MAPTFFAR1APPBCHE
SCHEMBL12138257 0.77 AR (0.46) GRIA1CACNG8NOTUMPDE3BPDE3A
SCHEMBL5955310 0.74 HPGD (0.53) GRIA1CACNG8DRD2PDE3BPDE3A
SCHEMBL5669695 0.73 BCHE (0.53) FFAR1APPBCHEACHEHSD17B1
SCHEMBL15474243 0.73 HSD17B1 (0.51) CHEK2MAPTFFAR1APPBCHE
SCHEMBL30167010 0.72 CHEK2 (0.47) CHEK2FFAR1APPBCHEACHE
SCHEMBL16649884 0.72 CYP1A2 (0.55) CHEK2FFAR1HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115768761-B Novel benzimidazole derivatives 卡尔那生物科学株式会社 2025-02-25 — — CN disclosed
US-20240279205-A1 NOVEL BENZIMIDAZOLE DERIVATIVE CARNA BIOSCIENCES, INC. (JP) 2024-08-22 — — US disclosed
CN-115768761-A Novel benzimidazole derivatives 卡尔那生物科学株式会社 2023-03-07 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240279205-A1 NOVEL BENZIMIDAZOLE DERIVATIVE STING1, IRF3, TBK1 BRAF 363/4885CHEK2 74/4885GRIA1 2179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback